Simpler Grants.gov #RFA-CA-27-006

NCI Seeks Research Bases for Community Oncology Clinical Trials Program

The National Cancer Institute (NCI) is seeking established organizations to serve as Research Bases for the NCI Community Oncology Research Program (NCORP): - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI) - Scope of Work: - Lead, design, and conduct multi-institutional clinical trials and studies in cancer control, prevention, screening, care delivery, and quality-of-life outcomes - Provide scientific and statistical leadership, manage study operations and data, ensure regulatory compliance, and support community and academic research sites - Eligibility and Participation: - Open to government entities, educational institutions, nonprofits, and certain businesses with significant cancer research expertise - Foreign organizations are not eligible, but non-U.S. components of U.S. organizations may participate - Funding Details: - Total available funding: $74,500,000 - Up to seven awards expected - Notable Requirements: - No specific OEMs or vendors are named, as this is a research program support opportunity, not a product procurement - Emphasis on leadership in cancer clinical research, data management, regulatory compliance, and support for community-based research - Place of Performance: - National Institutes of Health (NIH)

No product line items or OEMs are specified, as the opportunity focuses on research program services.

Description

This Notice of Funding Opportunity (NOFO) from the National Cancer Institute (NCI) seeks to fund the NCORP Research Bases, which are responsible for designing and conducting multi-institutional cancer control, prevention, and care delivery clinical research, including quality-of-life studies embedded in treatment and imaging studies. The Research Bases must provide scientific and statistical leadership, manage study operations and data, ensure compliance with regulations, and support community and academic sites. The program aims to enhance generalizability and dissemination of clinical trial results through community settings, engaging cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery.

View original listing